Baird Raises HCA Healthcare Price Target to $409 From $393
Baird maintained its Neutral rating on HCA Healthcare while raising its price target to $409 per share from $393.
Related stories
West Pharmaceutical Services Reports Quarterly Results
West Pharmaceutical Services reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 01:33 PM UTC
Nasdaq volatility trading pause begins at 9:30 a.m.
M impact | EQUITY | Oct 29, 2026, 01:33 PM UTC
Alphabet shares fall 13%, set to erase $489 billion in value. $GOOGL
L impact | EQUITY | Oct 29, 2026, 01:33 PM UTC
Mobileye Q3 Adjusted Earnings Rise, Revenue Falls; Narrows 2026 Outlook
Mobileye reported higher adjusted earnings and lower revenue for fiscal Q3, and narrowed its 2026 revenue outlook.
M impact | EQUITY | Oct 29, 2026, 01:33 PM UTC
Dream Finders Homes Reports $996 Million Q3 Revenue, Record Closings
Dream Finders Homes reported third-quarter 2026 revenue of $996.0 million and net income attributable to the company of $6.7 million. Homebuilding revenue rose 3% year over year, g
M impact | EQUITY | Oct 29, 2026, 01:33 PM UTC
Alphabet Shares Hit Near Seven-Month Low After Revenue Miss, Worsening Cash Burn
Alphabet shares hit a near seven-month low after a quarterly revenue miss and worsening cash burn.
M impact | EQUITY | Oct 29, 2026, 01:33 PM UTC